Literature DB >> 17195456

Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis.

Satoshi Ohno1, Yumiko Ohno, Hiroshi Nakada, Nobutaka Suzuki, Gen-Ichiro Soma, Masaki Inoue.   

Abstract

BACKGROUND: Although many tumors arising from epithelial tissues produce mucins, little is known regarding the biological significance of mucins in cancer. Recent researches have revealed that mucins produced by cancer cells play a critical role in the initial induction of cyclooxygenase (COX)-2 in the tumor microenvironment. Moreover, the consequence of abnormal glycosylation and overexpression of mucins includes suppression of the host-immune function.
MATERIALS AND METHODS: The expression of Tn/sialyl-Tn (s-Tn) antigen and its impact on COX-2 expression by tumor cells and infiltration of CD8+ T-cell into the cancer cell nest (nest CD8) in endometrial cancer was evaluated. Tissue specimens from 70 endometrial cancer patients who had undergone a curative resection were evaluated for Tn/s-Tn antigen, COX-2 and CD8 by immunohistochemistry.
RESULTS: The overexpression of Tn and s-Tn antigen was significantly correlated with COX-2 overexpression (p <0.005 and p <0.001, respectively). There was a significant association between s-Tn overexpression and low infiltration of nest CD8 (p<0.05). Strong expression of s-Tn antigen was significantly associated with poor prognosis (p < 0. 005). Among several prognostic factors, s- Tn expression remained the strong independent predictor of survival by multivariate analysis (p<0.05).
CONCLUSION: These results suggested that tumor-produced mucins, which were associated with COX-2 induction and immunosuppression, provided additional prognostic information in endometrial cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195456

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways.

Authors:  Chiung-Hua Huang; Jih-Hwa Guh; Grace Shiahuy Chen; Pin-Hsuan Lu; Ji-Wang Chern
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-08       Impact factor: 3.000

Review 2.  Mucins in pancreatic cancer and its microenvironment.

Authors:  Sukhwinder Kaur; Sushil Kumar; Navneet Momi; Aaron R Sasson; Surinder K Batra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-16       Impact factor: 46.802

3.  Mucin-type sialyl-Tn antigen is associated with PD-L1 expression and predicts poor clinical prognosis in breast cancer.

Authors:  Feng Xu; Hongying Zhao; Jie Li; Hongchuan Jiang
Journal:  Gland Surg       Date:  2021-07

4.  Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

Authors:  Avery D Posey; Robert D Schwab; Alina C Boesteanu; Catharina Steentoft; Ulla Mandel; Boris Engels; Jennifer D Stone; Thomas D Madsen; Karin Schreiber; Kathleen M Haines; Alexandria P Cogdill; Taylor J Chen; Decheng Song; John Scholler; David M Kranz; Michael D Feldman; Regina Young; Brian Keith; Hans Schreiber; Henrik Clausen; Laura A Johnson; Carl H June
Journal:  Immunity       Date:  2016-06-21       Impact factor: 31.745

5.  MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.

Authors:  Teresa L Tinder; Durai B Subramani; Gargi D Basu; Judy M Bradley; Jorge Schettini; Arefayene Million; Todd Skaar; Pinku Mukherjee
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

6.  Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.

Authors:  José Alexandre Ferreira; Paula A Videira; Luís Lima; Sofia Pereira; Mariana Silva; Mylène Carrascal; Paulo F Severino; Elisabete Fernandes; Andreia Almeida; Céu Costa; Rui Vitorino; Teresina Amaro; Maria J Oliveira; Celso A Reis; Fabio Dall'Olio; Francisco Amado; Lúcio Lara Santos
Journal:  Mol Oncol       Date:  2013-03-21       Impact factor: 6.603

7.  Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.

Authors:  Yasunori Hashiguchi; Mari Kasai; Takeshi Fukuda; Tomoyuki Ichimura; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Pathol Oncol Res       Date:  2015-12-17       Impact factor: 3.201

Review 8.  Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.

Authors:  Liliana R Loureiro; Mylène A Carrascal; Ana Barbas; José S Ramalho; Carlos Novo; Philippe Delannoy; Paula A Videira
Journal:  Biomolecules       Date:  2015-08-11

9.  Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy.

Authors:  L Lima; P F Severino; M Silva; A Miranda; A Tavares; S Pereira; E Fernandes; R Cruz; T Amaro; C A Reis; F Dall'Olio; F Amado; P A Videira; L Santos; J A Ferreira
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

10.  Mass Spectrometric Mapping of Glycoproteins Modified by Tn-Antigen Using Solid-Phase Capture and Enzymatic Release.

Authors:  Weiming Yang; Minghui Ao; Angellina Song; Yuanwei Xu; Lori Sokoll; Hui Zhang
Journal:  Anal Chem       Date:  2020-06-16       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.